influenza
vaccin
recommend
care
patient
chronic
obstruct
pulmonari
diseas
copd
clearli
reduc
acut
influenza
respiratori
ill
late
exacerb
copd
occur
week
vaccin
sever
exacerb
requir
mechan
ventil
although
signific
increas
occurr
local
advers
reaction
follow
vaccin
lifethreaten
condit
sever
respiratori
distress
diffus
pulmonari
opac
rare
occur
seven
case
influenza
vaccineinduc
interstiti
lung
diseas
ild
report
report
herein
case
elderli
patient
sever
copd
develop
fever
worsen
respiratori
symptom
sever
hypoxemia
requir
ventilatori
support
shortli
influenza
vaccin
diagnosi
acut
eosinophil
pneumonia
made
bronchoscopi
bronchoalveolar
lavag
bal
clinic
symptom
radiograph
abnorm
improv
follow
system
corticosteroid
treatment
thai
man
sever
copd
present
increas
breathless
fever
day
also
gener
malais
myalgia
cough
scant
sputum
physic
examin
temperatur
respiratori
rate
heart
rate
beatsmin
blood
pressur
mmhg
oxygen
satur
room
air
lung
auscult
reveal
coars
crackl
wheez
bilater
lower
lung
three
month
prior
experienc
acut
copd
exacerb
requir
routin
copd
medic
inhal
salmeterolfluticason
ipratropium
bromid
acut
respiratori
failur
diffus
pulmonari
opac
unusu
manifest
follow
influenza
vaccin
report
herein
patient
chronic
obstruct
pulmonari
diseas
develop
fever
worsen
respiratori
symptom
sever
hypoxemia
requir
ventilatori
support
shortli
influenza
vaccin
bronchoalveolar
lavag
compat
acut
eosinophil
pneumonia
rapid
clinic
improv
observ
week
system
corticosteroid
treatment
follow
radiograph
improv
week
diseas
recurr
observ
followup
initi
laboratori
test
reveal
white
blood
cell
wbc
count
l
neutrophil
lymphocyt
monocyt
eosinophil
blood
chemistri
normal
except
albumin
gl
normal
gl
initi
chest
radiograph
reveal
multipl
patchi
andor
peribronchi
opac
lung
notabl
right
upper
lobe
figur
sputum
collect
inadequ
microbiolog
analysi
test
nasopharyng
swab
influenza
common
respiratori
virus
multiplex
pcr
neg
intraven
ceftriaxon
oral
azithromycin
given
follow
treatment
continu
daili
fever
without
clinic
improv
becam
hypoxem
day
later
room
air
arteri
blood
gase
reveal
ph
pco
mmhg
po
mmhg
subsequ
requir
noninvas
ventil
eventu
mechan
ventil
comput
tomographi
ct
scan
chest
figur
b
c
reveal
multifoc
area
airspac
consolid
involv
bilater
lower
lobe
right
middl
lobe
larg
area
groundglass
opac
superimpos
interlobular
septal
thicken
right
upper
lobe
underw
bronchoscopi
bal
transbronchi
lung
biopsi
via
right
upper
lobe
day
hospit
analysi
bal
fluid
reveal
wbc
count
l
neutrophil
macrophag
lymphocyt
eosinophil
gram
stain
acidfast
bacillu
afb
stain
pcr
test
tuberculosi
tb
multiplex
pcr
common
respiratori
virus
adenoviru
coronaviru
respiratori
syncyti
viru
etc
fungal
stain
bacteri
cultur
bal
fluid
neg
repeat
blood
count
show
wbc
count
l
neutrophil
lymphocyt
monocyt
eosinophil
fresh
smear
parasit
exampl
strongyloid
larva
ascari
neg
transbronchi
lung
biopsi
specimen
show
evid
granuloma
malign
antimicrobi
discontinu
intraven
dexamethason
mg
administ
everi
h
patient
fever
subsid
dyspnoea
markedli
improv
h
treatment
oral
prednisolon
mg
daili
given
instead
followup
chest
ct
obtain
week
later
reveal
substanti
improv
oral
prednisolon
gradual
taper
next
week
cultur
tb
fungu
bal
fluid
neg
return
baselin
respiratori
condit
complet
resolut
radiograph
abnorm
recurr
observ
followup
number
interferon
gamma
ifng
interleukin
releas
cell
peripher
blood
measur
elispot
assay
mabtech
sweden
upon
stimul
influenza
vaccin
strong
ifng
respons
demonstr
two
healthi
agematch
adult
spotsform
cell
sfc
peripher
blood
mononuclear
cell
pbmc
respect
strain
inactiv
influenza
vaccin
given
period
contrast
magnitud
ifng
respons
much
lower
patient
pbmc
number
cell
bare
detect
patient
pbmc
found
two
control
individu
influenza
vaccin
current
recommend
everi
patient
copd
despit
benefit
seriou
advers
event
follow
vaccin
occur
includ
neurolog
complic
syndrom
transvers
myeliti
anaphylaxi
nevertheless
acut
respiratori
distress
diffus
pulmonari
opac
present
case
rare
date
seven
case
influenza
vaccineinduc
ild
follow
pandem
influenza
season
influenza
vaccin
report
onset
respiratori
symptom
rang
day
vaccin
age
patient
rang
year
fever
dyspnoea
common
complaint
four
seven
patient
preexist
lung
diseas
includ
idiopath
pulmonari
fibrosi
lung
cancer
postlobectomi
pneumothorax
extrins
allerg
alveol
one
case
underli
diseas
six
seven
case
improv
system
corticosteroid
administr
previou
report
increas
lymphocyt
count
bal
fluid
lymphocyt
infiltr
lung
biopsi
specimen
posit
reaction
influenza
vaccin
druginduc
lymphocyt
stimul
test
differ
case
eosinophil
higher
lymphocyt
bal
fluid
although
criteria
diagnosi
eosinophil
pneumonia
acut
day
subacut
month
durat
requir
bal
eosinophil
count
sever
case
met
diagnost
criterion
prior
corticosteroid
treatment
present
case
might
affect
eosinophil
count
blood
eosinophil
count
rare
initi
increas
time
present
case
lung
biopsi
gener
requir
possibl
caus
eosinophil
pneumonia
includ
parasit
infest
druginduc
eosinophilia
dust
toxic
substanc
exposur
exclud
recent
exposur
influenza
vaccin
plausibl
associ
although
immunopathogenesi
eosinophil
pneumonia
current
unknown
evid
cytokinepredomin
low
cytokin
ifng
respons
syndrom
specul
aberr
axi
toward
influenza
vaccin
confirm
low
frequenc
influenzaspecif
ifng
releas
cell
compar
releas
cell
patient
might
respons
least
part
develop
eosinophil
pneumonia
addit
compens
proinflammatori
cytokin
tumour
necrosi
factor
tnf
could
exert
cytokin
storm
effect
due
defect
influenzaspecif
ifng
respons
patient
contribut
acut
lung
injuri
system
inflammatori
respons
previous
demonstr
cytokin
receptor
gene
knockout
mice
upregul
cytokin
upon
viral
infect
could
respons
cytokin
storm
potenti
occur
mice
hyperinflammatori
respons
possibl
manifest
endotheli
dysfunct
increas
pulmonari
capillari
permeabl
sepsi
syndrom
conclus
influenza
vaccin
may
caus
seriou
advers
effect
patient
preexist
chronic
respiratori
diseas
rapid
respiratori
deterior
diffus
pulmonari
opac
vaccin
rais
concern
regard
influenza
vaccineinduc
ild
includ
acut
eosinophil
pneumonia
prompt
diagnosi
treatment
allevi
potenti
fatal
complic
conflict
interest
none
declar
